Synergism of wt-p53 and synthetic material in local nano-TAE gene therapy of hepatoma: comparison of four systems and the possible mechanism

[1]  H. El‐Serag,et al.  Epidemiology and Management of Hepatocellular Carcinoma. , 2019, Gastroenterology.

[2]  Costas D. Arvanitis,et al.  Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood–tumor barrier disruption , 2018, Proceedings of the National Academy of Sciences.

[3]  Jing Wang,et al.  Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy , 2018, Nature Communications.

[4]  P. Brastianos,et al.  Reactive astrocytic S1P3 signaling modulates the blood–tumor barrier in brain metastases , 2018, Nature Communications.

[5]  G. Garcia,et al.  Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real‐world experience from 1998 to 2015 , 2018, Cancer.

[6]  T. Vogl,et al.  Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation. , 2018, European journal of radiology.

[7]  P. Baglioni,et al.  Enhanced formation of hydroxyapatites in gelatin/imogolite macroporous hydrogels. , 2018, Journal of colloid and interface science.

[8]  Jennifer S. Yu,et al.  Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy. , 2017, Cell stem cell.

[9]  Dong-ping Wang,et al.  Comparison between liver resection and liver transplantation on outcomes in patients with solitary hepatocellular carcinoma meeting UNOS criteria: a population-based study of the SEER database , 2017, Oncotarget.

[10]  P. Layrolle,et al.  Impact of biomaterial microtopography on bone regeneration: comparison of three hydroxyapatites , 2017, Clinical oral implants research.

[11]  K. Kichikawa,et al.  Techniques to Form a Suitable Lipiodol-Epirubicin Emulsion by Using 3-Way Stopcock Methods in Transarterial Chemoembolization for Liver Tumor. , 2017, Journal of vascular and interventional radiology : JVIR.

[12]  F. Babonneau,et al.  Hydroxyapatites: Key Structural Questions and Answers from Dynamic Nuclear Polarization. , 2017, Analytical chemistry.

[13]  Ł. John,et al.  Designing of macroporous magnetic bioscaffold based on functionalized methacrylate network covered by hydroxyapatites and doped with nano-MgFe2O4 for potential cancer hyperthermia therapy. , 2017, Materials science & engineering. C, Materials for biological applications.

[14]  E. Kurek,et al.  Effect of carbonate substitution on physicochemical and biological properties of silver containing hydroxyapatites. , 2017, Materials science & engineering. C, Materials for biological applications.

[15]  Y. Millot,et al.  Incorporation of vanadium into the framework of hydroxyapatites: importance of the vanadium content and pH conditions during the precipitation step. , 2017, Physical chemistry chemical physics : PCCP.

[16]  J. Coey,et al.  Fe-Doping-Induced Magnetism in Nano-Hydroxyapatites. , 2017, Inorganic chemistry.

[17]  Daidi Fan,et al.  Monodisperse selenium-substituted hydroxyapatite: Controllable synthesis and biocompatibility. , 2017, Materials science & engineering. C, Materials for biological applications.

[18]  Marc Behl,et al.  Engineering biodegradable micelles of polyethylenimine-based amphiphilic block copolymers for efficient DNA and siRNA delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[19]  G. Gómez-Moreno,et al.  Influence of hydroxyapatite granule size, porosity, and crystallinity on tissue reaction in vivo. Part A: synthesis, characterization of the materials, and SEM analysis. , 2016, Clinical oral implants research.

[20]  J. Granjeiro,et al.  Physico-chemical and Histomorphometric Evaluation of Zinc-containing Hydroxyapatite in Rabbits Calvaria. , 2016, Brazilian dental journal.

[21]  V. Mazzaferro,et al.  Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses , 2016, Oncotarget.

[22]  H. Uludaǧ,et al.  A Delicate Balance When Substituting a Small Hydrophobe onto Low Molecular Weight Polyethylenimine to Improve Its Nucleic Acid Delivery Efficiency. , 2015, ACS applied materials & interfaces.

[23]  Rajendran J C Bose,et al.  Influence of cationic lipid concentration on properties of lipid–polymer hybrid nanospheres for gene delivery , 2015, International journal of nanomedicine.

[24]  Young Sook Lee,et al.  Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy. , 2015, Biomacromolecules.

[25]  M. Barone,et al.  MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma , 2015, Expert review of gastroenterology & hepatology.

[26]  Bing Ou,et al.  Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro. , 2015, International journal of oncology.

[27]  Y. Durocher,et al.  Surface modification of nonviral nanocarriers for enhanced gene delivery. , 2014, Nanomedicine.

[28]  L. Ye,et al.  The cooperative effect of p53 and Rb in local nanotherapy in a rabbit VX2 model of hepatocellular carcinoma , 2013, International journal of nanomedicine.

[29]  B. Luo,et al.  Antitumoural hydroxyapatite nanoparticles‐mediated hepatoma‐targeted trans‐arterial embolization gene therapy: in vitro and in vivo studies , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[30]  L. Roberts,et al.  Epidemiology and management of hepatocellular carcinoma. , 2010, Infectious disease clinics of North America.

[31]  Huifang Liang,et al.  Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor‐α in chemotherapy of multidrug‐resistant hepatocellular carcinoma , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[32]  Meizhen Yin,et al.  Internalization of hydroxyapatite nanoparticles in liver cancer cells , 2008, Journal of materials science. Materials in medicine.

[33]  P. Krammer,et al.  Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis. , 2008, Blood.

[34]  M. R. Mozafari,et al.  Importance of divalent cations in nanolipoplex gene delivery. , 2007, Journal of pharmaceutical sciences.

[35]  L. Ye,et al.  The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance , 2007, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[36]  Meizhen Yin,et al.  Sonochemical preparation of hydroxyapatite nanoparticles stabilized by glycosaminoglycans. , 2007, Ultrasonics sonochemistry.

[37]  Xiao-ping Chen 陈孝平,et al.  The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance , 2007, Journal of Huazhong University of Science and Technology.

[38]  P. Frayssinet,et al.  Bone cell transfection in tissue culture using hydroxyapatite microparticles. , 2006, Journal of biomedical materials research. Part A.

[39]  S. L. Hyatt,et al.  Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles , 2006, Gene Therapy.

[40]  Mark E. Davis,et al.  A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results. , 2005, Bioconjugate chemistry.

[41]  Mihail C Roco,et al.  Environmentally responsible development of nanotechnology. , 2005, Environmental science & technology.

[42]  V. Colvin.  The potential environmental impact of engineered nanomaterials , 2003, Nature Biotechnology.

[43]  D. Maysinger,et al.  Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles , 2003, Science.

[44]  Dai Hong-lian,et al.  Selective anti-hepatoma treated with titanium oxide nanoparticlesin vitro , 2003 .

[45]  A. Urtti,et al.  Different synergistic roles of small polyethylenimine and Dosper in gene delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[47]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[48]  W. Zauner,et al.  In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[49]  S. Orrenius,et al.  Tumor necrosis factor alpha induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear free Ca2+ concentration and DNA fragmentation. , 1992, Cancer research.